Image

Breast Cancer Symposium | Evaluation Questionnaire

BCS | Evaluation Questionnaire
(1-Not Likely to 5-Very Likely)
I attest that I have completed this educational activity in its entirety. *
Were faculty disclosures made prior to the start of the CME activity? *

Please rate whether the following educational objectives were met.

Review the modern surgical approaches addressed in the patient encounter *
Discuss updates in breast cancer imaging for earlier detection *
Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu overexpressing and triple negative breast cancer *
Review advances in radiation therapy and outcomes *
Identify risk factors and endocrine interventions in patients high risk for developing breast cancer *
Discuss the role of hereditary genetics and the implication to the patient and their families *

Please rate the projected impact of this activity on your knowledge, competence, performance, and patient outcomes:

This activity increased my knowledge. *
This activity increased my competence. *
This activity increased my performance. *
This activity increased my patient outcomes. *

Do you feel the activity was scientifically sound and free of commercial bias or influence?

Do you feel the activity was scientifically sound and free of commercial bias or influence?

Please identify how you will change your practice as a result of attending this activity.

This activity validated my current practice. No changes will be made. *
Create/revise protocols, policies, and/or procedures *
Change the management and/or treatment of my patients *
Please indicate any barriers you perceive in implementing these changes. *
Will you attempt to address these barriers in order to implement changes in your competence, performance, and/or patients' outcomes? *
The content of this activity matched my current (or potential) scope of practice. *

Please rate the following faculty - Friday, September 24th:

RADIOLOGY: Breast Cancer Imaging: Current & Future — Dr. Elizabeth Morris (UC Davis)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

PATHOLOGY: What Are We Looking For? — Dr. Anna Boguniewicz (AMC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

PATHOLOGY: Special Subtypes — Dr. Edi Brogi (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Updates in Hereditary Risk Factors — Dr. Mark Robson (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Management of the High-Risk Patient — Dr. Mary Gemignani (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Metabolic & Energy Balance Pertubations in Breast Cancer Pathogenesis and Treatment — Dr. Neil
Iyengar (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Managing Breast Cancer in the Older Patient — Dr. Hyman Muss (UNC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Molecular Drivers and Advances in the Management of Hormone Receptor Positive HER2neu
Negative Early and Advanced Breast Cancer — Dr. Claudine Isaacs (GU)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Please rate the following faculty - Saturday, September 25th:

KEYNOTE LECTURE: The Global Impact of the Pandemic on Oncologic Care
— Dr. Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer American Society of Clinical Oncology

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Triple-negative Breast Cancer: Early Stage — Dr. Tiffany Traina (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Triple-negative Breast Cancer: Late Stage — Dr. Rita Nanda (UOC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Tailoring Adjuvant Therapy for Early Stage HER2+ Breast Cancer — Dr. Edith Perez (MAYO)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

HER2+ Metastatic Breast Cancer — Dr. Chau Dang (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

IMMUNOTHERAPY AND BREAST CANCER THE SCIENCE AND THE PATIENT - Dr. George Plitas (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

IMMUNOTHERAPY AND BREAST CANCER THE SCIENCE AND THE PATIENT - Dr. Heather McArthur (UT
Southwestern)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

The Evolving Role of Radiation Therapy and Neoadjuvant Systemic Therapy — Dr. Tia Olds (NYOH)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Updates in Who Should Receive and Who Can Avoid Adjuvant Breast Radiation — Dr. Yasmin Hasan
(UoC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Please rate the following faculty - Sunday, September 26th:

ARENA ADVOCACY LECTURE: Rethinking Dose and Schedule in Cancer Therapeutics — Dr. Larry Norton
(MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Art in Medicine — Dr. Francis Arena (NYU Langone)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

De Novo Oligo Metastatic Breast Cancer – Now what? Case Presentation 1 — Dr. Loren Rourke (US
Oncology)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

De Novo Oligo Metastatic Breast Cancer – Now what? Presentation and Discussion — Dr. Eleftherios
Mamounas (UF)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

De-Escalation of Local Therapy after Neoadjuvant Chemotherapy – Does that Work? Case Presentation 2
— Dr. Loren Rourke (US Oncology)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

De-Escalation of Local Therapy after Neoadjuvant Chemotherapy – Does that Work? Presentation and
Discussion — Dr. Andrea Barrio (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Breast Reconstruction — Dr. Joseph Disa (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

BREAST CANCER AND THE LUNG — Dr. Dennis Rassias (SPH)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

BREAST CANCER AND THE BRAIN — Dr. Ahmed Meleis (AMC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

BRAIN METASTASES: NonHER2neu BRAIN METASTASES: HER2neu + - Dr. Andrew Seidman (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

BRAIN METASTASES: NonHER2neu BRAIN METASTASES: HER2neu + - Dr. Shanu Modi (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *
What is your overall evaluation of this CME activity? *